Researchers gain quantum control of an oscillator

Superconducting circuits rely on an electronic component known as the Josephson junction, allowing them to manipulate quantum information and communicate with photons. Using a stimulated Josephson non-linearity, a team of researchers at Princeton University, Northwestern University, and the University of Chicago directly operated an oscillator. By operating it as an isolated two-level system, the team achieved quantum control of an oscillator by modifying its Hilbert space.  The researchers believe that the new approach for controlling oscillators will allow the production of substantially more energy-efficient electronic components than most of the chips used today.

Reference Link:https://phys.org/news/2019-12-quantum-oscillator-josephson-circuit.html

The future of computing could be Magnetic

Researchers at Massachusetts Institute of Technology (MIT) have developed an innovative new circuit that allows for precise computing without the need for electricity. The novel design instead relies on magnetic waves- an advance that ignites hope towards practical magnetic-based devices, which have the potential to compute far more efficiently than electronics. The new circuit design offers a path to “spintronic” devices that use little electricity and practically generate no heat. Researchers assume that such interference-based spintronic devices, like quantum computers, could execute highly complex tasks that conventional computers struggle with.

Reference Link:https://www.sciencedaily.com/releases/2019/11/191128172218.htm

Protein that can help in the treatment of leukemia

Scientists at UCLA have discovered a protein produced by a gene known as MLLT3 and its connection to the self-renewal of human blood stem cells. The scientists observed that activating the protein causes blood cells to self-renew at least twelvefold in laboratory conditions. The finding which was published in the journal Nature is very much significant as cancers such as leukemia can be effectively treated using blood stem cells, also known as Hematopoietic stem cells (HSCs), produced outside the human body. Moreover, it could serve as an alternative to existing treatment options for many inherited blood diseases as well as bone marrow transplants.

Reference Link: https://medicalxpress.com/news/2019-11-protein-human-blood-stem-cell.html

Neurotransmitter dopamine influences childhood asthma

According to new research published in the journal Immunity, neurons that produce the neurotransmitter dopamine communicate with T cells to intensify allergic inflammation in the lungs of young mice but not older mice. The findings rationalize that children are more susceptible to developing allergic asthma than adults. An estimated 6 million children have allergic asthma, making asthma one of the most common long-term diseases of childhood. By emphasizing the significant role of interactions between the nervous system and the immune system in childhood asthma, the results could lead to new approaches for treating the common chronic disease.

Reference Link: https://medicalxpress.com/news/2019-11-evidence-mice-childhood-asthma-neurotransmitter.html

Chloroquine with TB antibiotic may reduce drug resistance

A research conducted by scientists at the Indian Institute of Science and Tata Institute of Fundamental Research found that administering anti-malarial drug Chloroquine with anti-TB drugs can reduce the tolerance of TB bacteria towards it. That, in turn, can help fight drug-resistant TB. In their work, the researchers noted that one of the things that make fighting TB so difficult is that the bacteria are able to increase the acidity in the area where they reside. So the researchers gave patients chloroquine to reduce acidity, along with another drug to sneak in and take out the TB bacteria. The researchers report that their idea worked in both mice and guinea pigs, reducing treatment time to just eight weeks.

Reference Link: https://medicalxpress.com/news/2019-11-chloroquine-tuberculosis-bacteria-susceptible-antimalarial.html

World’s first AI University at Abu Dhabi offers 100% scholarships

Abu Dhabi has just launched the “world’s first AI university” in the city of in Masdar City known as the Mohammad Bin Zayed University of Artifical Intelligence (MBZUAI). Abu Dhabi is also one of the first nations to appoint a minister for artificial intelligence in 2017.

MBZUAI’s website mentions that “a graduate-level, research-based academic institution that offers specialized degree programs for local and international students in the field of Artificial Intelligence.” Shaikh Mohammad Bin Zayed Al Nahyan, Abu Dhabi’s crown prince tweeted “Launching of the world’s first graduate-level artificial intelligence university in Abu Dhabi echoes the UAE’s pioneering spirit, and paves the way towards a new era of innovation and technological advancement that benefits the UAE and a world.”

Reference Link: https://www.theweek.in/news/sci-tech/2019/10/16/uae-launches-worlds-first-ai-university-with-100-scholarships.html

Peer reviewers share their concerns in global survey

Based on a survey of 4,700 researchers worldwide, The Grant Review In Focus reported that recognition is how reviewers feel rewarded. A significant number of people who took the survey agreed that they would more likely write a review for a paper if the funders agree to acknowledge their efforts.

According to International Journal of Science called Nature, about “two-thirds of those surveyed were satisfied with the process overall” and 78% believe that peer review is a best way to get research funds. There is still a large portion of people who disagreed with this because they believe peer review of such kind is never fair and unbiased.

Reference Link: https://www.nature.com/articles/d41586-019-03105-2

Is true that corporate funded research is often far from truth?

Over the last two decades, government and non-profit funding has witnessed a significant decline while Industry or corporate funded research has seen a global growth. Two-thirds of medical research is now dominated by corporates since they fund it and that does not make things any good for the medical community. However, this practice is growing increasingly common among all prominent industries such as food and beverage, pharmaceutical, etc.

Because of this interference of other industries in the medical community, the research conducted is often not accurate or based on facts. It has been alleged that industries fund for research to pave the results in their favor although the funders has always been denying. This manipulation tamper’s with the trust of the funder’s consumer since they never really get to know the real deal and have to trust what the tampered results have to discuss.

Reference Link: https://theconversation.com/when-big-companies-fund-academic-research-the-truth-often-comes-last-119164

Tough breast cancer can be treated using an anti-evolution drug

New generation remedies for cancer treatments are challenging resilient cancer conditions in patients. Previously known as BOS172722, was tested in animals to study the effectiveness of paclitaxel which is kind of Chemotherapy used in treating triple-negative breast cancer, one of deadliest breast cancer known to mankind.

A human trial of this procedure is scheduled to be performed. If it is a success, it can be expanded to treat lung and ovarian cancer.

Reference Link: https://www.newscientist.com/article/2218935-anti-evolution-drug-may-help-treat-resistant-breast-cancers/

Alzheimer’s Association And Wiley Collaborate For Publishing

John Wiley and Sons Inc. and the Alzheimer’s Association partnered for their three publications namely Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association (A&D), Diagnosis, Assessment & Disease Monitoring (DADM), and Translational Research & Clinical Interventions (TRCI).

The journals will changeover to the Wiley Online Library platform after the publication of the November/December 2019 issue. Maria C. Carrillo, a Ph.D. holder and Chief Science officer of Alzheimer’s Association says “The Association is committed to accelerating the international effort to eliminate these devastating diseases, and these journals are an important forum for sharing the latest research about Alzheimer’s and related dementias with the global scientific community.”

Reference Link: https://newsroom.wiley.com/press-release/all-corporate-news/alzheimers-association-and-wiley-announce-publishing-partnership